Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) is launching its enhanced Smart Health AI Stations across the United States.
The launch, in partnership with Manchester Marketing Group, will introduce AI-powered assessments capable of real-time vital signs screening and substance impairment detection.
The company said 10 units are being considered for potential demonstrations to corporate and government bodies across the country.
Predictmedix AI’s Smart Health AI Stations provide non-contact health screenings, using artificial intelligence to identify potential health risks and offer data-driven insights for proactive health management.
“The US launch of our Smart Health AI Stations marks an important step in our mission to advance proactive health management,” said Rahul Kushwah, COO of Predictmedix AI.
“Through our partnership with Manchester Marketing Group, we look forward to identifying opportunities to provide organizations with the tools they need to prioritize health, safety, and well-being.”
Manchester Marketing Group, which is working with partners across North, Central, and South America as well as the Caribbean, said demand for the technology is rising.
“We’re witnessing a paradigm shift in health management, and Predictmedix AI is at the forefront,” said James Cooke, marketing director for Manchester Marketing. "The Smart Health AI Stations offer tangible, immediate benefits, and we’re seeing exceptional interest across sectors."
The global population health management market, valued at nearly $33 billion in 2023, is projected to grow at a compound annual rate of 16.6% to reach $126 billion by 2032, with North America holding a dominant 64.8% market share, according to Fortune Business Insights.